{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:02:56Z","timestamp":1758672176628,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2269,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.virol.2006.11.020","type":"journal-article","created":{"date-parts":[[2007,1,2]],"date-time":"2007-01-02T13:50:55Z","timestamp":1167745855000},"page":"356-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals"],"prefix":"10.1016","volume":"361","author":[{"given":"Kendra M.","family":"Viner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heesun","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart N.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.virol.2006.11.020_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1566524033479843","article-title":"Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines","volume":"3","author":"Ahlers","year":"2003","journal-title":"Curr. Mol. Med."},{"issue":"10","key":"10.1016\/j.virol.2006.11.020_bib2","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.11.020_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","article-title":"Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene","volume":"341","author":"Aldaz-Carroll","year":"2005","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.virol.2006.11.020_bib4","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","article-title":"Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity","volume":"79","author":"Ami","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.11.020_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/0022-1317-23-2-197","article-title":"Neutralizing activities of antisera to poxvirus soluble antigens","volume":"23","author":"Appleyard","year":"1974","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2006.11.020_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.11.020_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"Buller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.virol.2006.11.020_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.virol.2006.11.020_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0140-6736(91)91636-9","article-title":"Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein","volume":"337","author":"Cooney","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2006.11.020_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2006.11.020_bib11","first-page":"5","article-title":"Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis","volume":"5","author":"Gilbert","year":"2005","journal-title":"Vaccine"},{"issue":"5597","key":"10.1016\/j.virol.2006.11.020_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.1074674","article-title":"Containing bioterrorist smallpox","volume":"298","author":"Halloran","year":"2002","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.virol.2006.11.020_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.virol.2006.11.020_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0264-410X(98)00238-2","article-title":"Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime","volume":"17","author":"Hanke","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.11.020_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/JVI.72.1.294-302.1998","article-title":"Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain","volume":"72","author":"Herrera","year":"1998","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2006.11.020_bib16","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/JVI.79.10.6554-6559.2005","article-title":"Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus","volume":"79","author":"Jackson","year":"2005","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2006.11.020_bib17","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1128\/IAI.73.9.5350-5357.2005","article-title":"Involvement of fractalkine\/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila","volume":"73","author":"Kikuchi","year":"2005","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.virol.2006.11.020_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2005.05.046","article-title":"IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors","volume":"24","author":"Klas","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virol.2006.11.020_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/hum.1996.7.4-489","article-title":"Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors","volume":"7","author":"Kolls","year":"1996","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.virol.2006.11.020_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.virol.2004.02.007","article-title":"Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion","volume":"322","author":"Kwak","year":"2004","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2006.11.020_bib21","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/JVI.78.6.2770-2779.2004","article-title":"Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes","volume":"78","author":"Legrand","year":"2004","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2006.11.020_bib22","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1128\/JVI.72.11.9267-9277.1998","article-title":"Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver","volume":"72","author":"Lieber","year":"1998","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2006.11.020_bib23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.it.2004.10.002","article-title":"25 years since the eradication of smallpox: why poxvirus research is still relevant","volume":"25","author":"Mahalingam","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.virol.2006.11.020_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/0-306-46817-4_34","article-title":"Intralesional vaccinia\/GM-CSF recombinant virus in the treatment of metastatic melanoma","volume":"465","author":"Mastrangelo","year":"2000","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virol.2006.11.020_bib25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.163.3.1449","article-title":"Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens","volume":"163","author":"Mata","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2006.11.020_bib26","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.161.6.2985","article-title":"The MHC class I-restricted immune response to HIV-gag in BALB\/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D","volume":"161","author":"Mata","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2006.11.020_bib27","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/JVI.72.3.2429-2438.1998","article-title":"The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation","volume":"72","author":"Mathew","year":"1998","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2006.11.020_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.virol.2006.11.020_bib29","first-page":"317","article-title":"Gene therapy with poxvirus vectors","volume":"7","author":"Moroziewicz","year":"2005","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"6347","key":"10.1016\/j.virol.2006.11.020_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/353852a0","article-title":"Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes","volume":"353","author":"Pamer","year":"1991","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.virol.2006.11.020_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0950268800052535","article-title":"The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur","volume":"116","author":"Pastoret","year":"1996","journal-title":"Epidemiol. Infect."},{"issue":"3","key":"10.1016\/j.virol.2006.11.020_bib32","first-page":"151","article-title":"The immune response to vaccinia virus is significantly reduced after scarification with TK\u2212 recombinants as compared to wild-type virus","volume":"44","author":"Phillpotts","year":"2000","journal-title":"Acta Virol."},{"issue":"11","key":"10.1016\/j.virol.2006.11.020_bib33","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1128\/JVI.73.11.9145-9152.1999","article-title":"Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses","volume":"73","author":"Qiu","year":"1999","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2006.11.020_bib34","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jgm.397","article-title":"Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer","volume":"5","author":"Rochlitz","year":"2003","journal-title":"J. Gene Med."},{"issue":"2","key":"10.1016\/j.virol.2006.11.020_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ymthe.2004.10.015","article-title":"Fighting cancer with vaccinia virus: teaching new tricks to an old dog","volume":"11","author":"Shen","year":"2005","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.virol.2006.11.020_bib36","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.169.8.4222","article-title":"Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes","volume":"169","author":"Shen","year":"2002","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.virol.2006.11.020_bib37","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2006.11.020_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0042-6822(86)90289-8","article-title":"Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria","volume":"150","author":"Steimer","year":"1986","journal-title":"Virology"},{"issue":"6812","key":"10.1016\/j.virol.2006.11.020_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.virol.2006.11.020_bib40","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1073\/pnas.101136398","article-title":"Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing","volume":"98","author":"Todo","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2006.11.020_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1099\/0022-1317-13-1-19","article-title":"Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus","volume":"13","author":"Turner","year":"1971","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virol.2006.11.020_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","article-title":"Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees","volume":"7","author":"Viner","year":"2005","journal-title":"Microbes Infect."},{"key":"10.1016\/j.virol.2006.11.020_bib43","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1128\/jvi.67.8.4732-4741.1993","article-title":"Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination","volume":"67","author":"Wolffe","year":"1993","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.11.020_bib44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/JVI.77.1.799-803.2003","article-title":"Overcoming immunity to a viral vaccine by DNA priming before vector boosting","volume":"77","author":"Yang","year":"2003","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206008713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206008713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:46:02Z","timestamp":1758584762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682206008713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0042682206008713"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2006.11.020","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2006.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}